hengrui glp-1 China Medicine has registered a Phase III, multicenter, randomized, double-blind clinical trial of the GLP-1R/GIPR dual agonist HRS9531 for the treatment of obesity (NCT06396429; HRS9531-301) Hengrui Pharma's GLP-1R Agonist Patent
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26


























![[Pre-Order] EXO - 11 MINI DOLL KEY RING / 2026 EXO PLANET #6 - EXhOrizon OFFICIAL MD Member:SUHO](https://cdn.shopify.com/s/files/1/0674/3041/6578/files/pre-order-exo-11-mini-doll-key-ring-2026-exo-planet-6-exhorizon-official-md-1200_c42079ce-fce8-4f10-a667-a6e229521ebe.jpg?v=1778669790)